Cassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims

Date:

September 26, 2024

Shares of Cassava Sciences Inc. dropped more than 10% in the extended session Thursday after announcing a settlement with U.S. securities regulators, who had charged the pharma company and two former executives for “misleading claims” about an Alzheimer’s clinical trial.

Source link

Runway earmarks $5M to fund up to 100 films using AI-generated video

Leftists Make Ridiculous Argument About X Suspending Journo Klippenstein, Who Doxxed JD Vance

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Cassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims

Recent posts

ASML says chip-market slump will mainly impact sales to China

RFK Jr. would rattle health markets as head of HHS, but his confirmation is far from certain, analyst says

Boeing’s defense chief is leaving, company says

Five Below is curbing its expansion plans. But shares are rallying.

Fed rate cuts may make ether more attractive after being left behind by bitcoin

Ulta Beauty’s same-store sales take a surprising turn, and retailer’s stock drops 8%

Starbucks stock rallies on hopes of a turnaround under its new CEO — the head of Chipotle Mexican Grill

Gold prices break a new record, but may be near a peak

DexCom’s stock is headed for its worst selloff ever. Not everyone thinks it’s justified.

U.K. borrowing costs rise in volatile trade after budget delivered

J.D. Vance warns of deliberate ‘bond-market death spiral’ if Trump is elected

Amazon hit with $5.9 million fine as California says it failed to disclose quotas to workers

Skechers shares rise on $1 billion buyback, more upbeat outlook

Oil prices extend gains on July 4 travel expectations, Hurricane Beryl worries

Tesla’s market cap hits $1 trillion after another Trump-fueled jump for the stock

Related articles

Biden needs to push through promised student-loan relief before Trump returns to White House, powerful Democrat warns

Why natural-gas prices have rallied 18% this week to a one-year high

Here’s Larry Summers’ advice to Trump on the economy and Elon Musk

Trump’s choice of Dr. Oz to oversee Medicare and Medicaid could be ‘devastating’ for millions of Americans

Buy gold after its pullbacks — because it may hit $3,000 in 2025

Bitcoin sits near record high. More good news for investors: It’s now less volatile.

RFK Jr. may start a food and drug ‘culture war.’ Investors are running for cover.

Here’s what bond and gold traders are signaling about Russia’s nuclear shift

Company

Follow us